These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 5451983)

  • 1. [First experience in the long term treatment with the antihypertensive Guancydin including studies of the renin-angiotensin system].
    Werning C; Schweikert HU; Stiel D; Vetter W; Siegenthaler W
    Dtsch Med Wochenschr; 1970 Aug; 95(35):1756-61. PubMed ID: 5451983
    [No Abstract]   [Full Text] [Related]  

  • 2. [Guanfacinum (BS 100-14) in long-term therapy of severe hypertension].
    Röckel A; Sabel B; Heidland A
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():314-8. PubMed ID: 347805
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experiences with Leron (guanacline) in the treatment of hypertension.
    Seedat YK
    S Afr Med J; 1970 May; 44(19):562-3. PubMed ID: 5420832
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of guanabenz on arterial pressure and the renin-aldosterone system in hypertensive patients].
    Rappelli A; Glorioso N; Tedde R; Madeddu P; Dessì Fulgheri P; Campus S
    Boll Soc Ital Cardiol; 1978; 23(1):177-83. PubMed ID: 754771
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relationship between renin-aldosterone system and efficacy of a beta-blocking agent in hypertensive patients].
    Armanini D; Guido R; Fallo F; Opocher G; Mantero F
    Clin Ter; 1976 Oct; 79(1):41-62. PubMed ID: 1017163
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of pindolol on arterial pressure and plasma renin activity in essential hypertension and in hypertension during chronic renal insufficiency].
    De Ferrari G; Gaiter A; Ginevri F; Tizianello A
    Clin Ter; 1979 Sep; 90(5):461-8. PubMed ID: 399210
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the antihypertensive efficacy of guanoxan].
    Ambrosioni E; Magelli C; Magnani B
    G Clin Med; 1977; 58(1-2):19-30. PubMed ID: 143388
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibition in renal and hypertensive disorders.
    Götz R; Heidbreder E; Heidland A
    Clin Physiol Biochem; 1990; 8 Suppl 1():25-32. PubMed ID: 2257721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new drug in the medical treatment of arterial hypertension: cyclazenin].
    Mameli P; Maioli M; Fanzecu P
    Rass Int Clin Ter; 1970 Apr; 50(8):457-64. PubMed ID: 4394494
    [No Abstract]   [Full Text] [Related]  

  • 10. [Beta-adrenergic blockers and renin-angiotensin-aldosterone system in healthy individuals and patients with arterial hypertension].
    Miranda B; Ruilope L; Mancheño E; Arribas F; García-Robles R; Alcázar JM; Nieto J; Sancho J; Rodicio JL
    Med Clin (Barc); 1984 Nov; 83(14):572-4. PubMed ID: 6513646
    [No Abstract]   [Full Text] [Related]  

  • 11. Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension.
    Rasmussen S; Ibsen H; Giese J
    Scand J Urol Nephrol Suppl; 1984; 79():49-52. PubMed ID: 6089319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical observations on the treatment of arterial hypertension with a new drug of a guanidine type: cyclazenine].
    Montagnani M; Bayelli PF; Antonelli A; Barducci O
    Clin Ter; 1968 Sep; 46(5):419-38. PubMed ID: 5747193
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term clinical experience with guanfacine.
    Fetkovská N; Brimichová G; Sebeková K; Dzúrik R
    Cor Vasa; 1987; 29(4 Suppl 1):23-9. PubMed ID: 3315447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Orthostatic dysregulations in hypertensive patients].
    Suchan P; Husmann F
    Munch Med Wochenschr; 1967 Jan; 109(4):176-80. PubMed ID: 6071796
    [No Abstract]   [Full Text] [Related]  

  • 15. [Behavior of plasma renin activity during treatment with alphamethyldopa].
    Arrigo F; Russo A; Virga T; Pitrone F; Coglitore S; Consolo F
    Boll Soc Ital Cardiol; 1977; 22(3):305-13. PubMed ID: 617276
    [No Abstract]   [Full Text] [Related]  

  • 16. [Saralasin for renovascular or essential hypertension (author's transl)].
    Arlart I; Rosenthal J
    Dtsch Med Wochenschr; 1978 Nov; 103(45):1790-6. PubMed ID: 710289
    [No Abstract]   [Full Text] [Related]  

  • 17. [Estulic in the long-term treatment of hypertension].
    Rhomberg F
    Schweiz Med Wochenschr; 1980 Dec; 110(50):1922-4. PubMed ID: 6782668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Variations of renin activity in hypertensive patients under aldactone therapy].
    Popov NG; Kiprov D; Astrug A; Dotschev D
    Med Welt; 1971 Jul; 22(29):1207-9. PubMed ID: 5566156
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term safety, tolerability, and antihypertensive efficacy of aliskiren, an oral direct renin inhibitor, in Japanese patients with hypertension.
    Kushiro T; Itakura H; Abo Y; Gotou H; Terao S; Keefe DL
    Hypertens Res; 2009 Mar; 32(3):169-75. PubMed ID: 19262478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol, renin and hypertension: a review.
    Laragh JH; Bühler FR
    Postgrad Med J; 1976; 52 Suppl 4(604):109-15. PubMed ID: 787950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.